Study of the Effect of Mometasone Furoate/Formoterol (MF/F), Montelukast and Beclomethasone Dipropionate (BDP) on Plasma Cortisol Levels of Children 5-11 Years Old With Persistent Asthma (P05574)

NCT01615874 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: MF/F Metered Dose Inhaler (MDI) 25/5 mcg
DRUG: MF/F MDI 50/5 mcg
DRUG: MF/F MDI 100/5 mcg
DRUG: BDP hydrofluoroalkane (HFA) 80 mcg
DRUG: Montelukast tablets 5 mg (4 mg for children 5 years of age)
DRUG: Rescue medication: short-acting beta-2 agonist (SABA) MDI
DRUG: Rescue medication: Prednisone/Prednisolone

Sponsor

Organon and Co